There is good reported concordance between MSI and immunohistochemistry testing for Lynch syndrome tumour identification,18 but more recent data suggest that MSI testing is less accurate in endometrial cancer – particularly at identifying MSH6 carriers.53 This evidence concerns the gene MSH6 and endometrial cancer.